Unraveling and Harnessing the Immune Response at the Cell-Biomaterial Interface for Tissue Engineering Purposes
Overview
Biotechnology
Affiliations
Biomaterials are defined as "engineered materials" and include a range of natural and synthetic products, designed for their introduction into and interaction with living tissues. Biomaterials are considered prominent tools in regenerative medicine that support the restoration of tissue defects and retain physiologic functionality. Although commonly used in the medical field, these constructs are inherently foreign toward the host and induce an immune response at the material-tissue interface, defined as the foreign body response (FBR). A strong connection between the foreign body response and tissue regeneration is suggested, in which an appropriate amount of immune response and macrophage polarization is necessary to trigger autologous tissue formation. Recent developments in this field have led to the characterization of immunomodulatory traits that optimizes bioactivity, the integration of biomaterials and determines the fate of tissue regeneration. This review addresses a variety of aspects that are involved in steering the inflammatory response, including immune cell interactions, physical characteristics, biochemical cues, and metabolomics. Harnessing the advancing knowledge of the FBR allows for the optimization of biomaterial-based implants, aiming to prevent damage of the implant, improve natural regeneration, and provide the tools for an efficient and successful in vivo implantation.
Bioceramic Surface Topography Regulating Immune Osteogenesis.
Hao J, Du L, He Y, Wu C BME Front. 2025; 6():0089.
PMID: 39850150 PMC: 11756600. DOI: 10.34133/bmef.0089.
Hierarchy Reproduction: Multiphasic Strategies for Tendon/Ligament-Bone Junction Repair.
Chen K, Liu Z, Zhou X, Zheng W, Cao H, Yang Z Biomater Res. 2025; 29():0132.
PMID: 39844867 PMC: 11751208. DOI: 10.34133/bmr.0132.
Emerging Non-Breast Implant-Associated Lymphomas: A Systematic Review.
Di Napoli A, Fruscione S, Mazzola S, Amodio R, Graziano G, Mannino R Cancers (Basel). 2024; 16(23).
PMID: 39682271 PMC: 11640267. DOI: 10.3390/cancers16234085.
He S, Zhang Q, Jia J, Xia W, Chen S, Min F Mater Today Bio. 2024; 29:101304.
PMID: 39498150 PMC: 11532915. DOI: 10.1016/j.mtbio.2024.101304.
Advancements and challenges in stem cell transplantation for regenerative medicine.
Wei L, Yan W, Shah W, Zhang Z, Wang M, Liu B Heliyon. 2024; 10(16):e35836.
PMID: 39247380 PMC: 11379611. DOI: 10.1016/j.heliyon.2024.e35836.